Related Experiment Video
Updated: Jan 10, 2026

09:59
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
14.6K
Early Post-Thrombectomy MRI Markers: Temporal Evolution and Association With Reperfusion and Clinical Outcome
Marie L Luby1, Amie W Hsia1,2, Sana Somani1,2
1Stroke Branch, NIH, Bethesda, MD.
Neurology
|November 24, 2025
Summary
Incomplete reperfusion after endovascular therapy (EVT) for ischemic stroke predicts poor outcomes and dynamic MRI changes. Identifying these imaging markers can guide future adjunctive therapy trials.
Area of Science:
- Neurology
- Radiology
- Cardiovascular Medicine
Background:
- Many patients undergoing endovascular therapy (EVT) for ischemic stroke have poor outcomes despite successful reperfusion.
- Identifying patients who could benefit from additional treatments is crucial.
Purpose of the Study:
- To investigate the association between incomplete reperfusion, evolution of imaging markers on early post-EVT MRI, and clinical outcomes in acute ischemic stroke patients.
Main Methods:
- Prospective enrollment of patients with anterior circulation large vessel occlusion stroke undergoing EVT.
- Serial MRI including early (<6 hours) and 24-hour scans to evaluate imaging markers.
- Correlation of imaging findings with reperfusion status and 30-day clinical outcomes (modified Rankin Scale).
Main Results:
- Incomplete reperfusion (54%) was linked to larger lesion volumes, increased edema, and lesion growth on follow-up MRI.
- Early complete reperfusion correlated with lower NIHSS scores and improved early neurologic improvement.
- Absence of mixed signal on diffusion-weighted imaging (DWI) MRI was a significant predictor of good clinical outcome at 30 days.
Conclusions:
- MRI markers reveal dynamic changes after EVT, highlighting incomplete reperfusion and reperfusion injury as key prognostic factors.
- The observed heterogeneity in imaging evolution suggests potential for therapeutic intervention post-EVT.
- Findings provide a basis for designing future clinical trials focused on adjunctive therapies targeting specific imaging biomarkers.

